Exact Mass: 433.2114
Exact Mass Matches: 433.2114
Found 500 metabolites which its exact mass value is equals to given mass value 433.2114
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Mycophenolate mofetil
Mycophenolate mofetil is only found in individuals that have used or taken this drug. It is the 2-morpholinoethyl ester of mycophenolic acid (MPA), an immunosuppressive agent, inosine monophosphate dehydrogenase (IMPDH) inhibitor.Mycophenolate mofetil is hydrolyzed to form mycophenolic acid (MPA), which is the active metabolite. MPA is a potent, selective, uncompetitive, and reversible inhibitor of inosine monophosphate dehydrogenase (IMPDH), and therefore inhibits the de novo pathway of guanosine nucleotide synthesis without incorporation into DNA. Because T- and B-lymphocytes are critically dependent for their proliferation on de novo synthesis of purines, whereas other cell types can utilize salvage pathways, MPA has potent cytostatic effects on lymphocytes. MPA inhibits proliferative responses of T- and B-lymphocytes to both mitogenic and allospecific stimulation. Addition of guanosine or deoxyguanosine reverses the cytostatic effects of MPA on lymphocytes. MPA also suppresses antibody formation by B-lymphocytes. MPA prevents the glycosylation of lymphocyte and monocyte glycoproteins that are involved in intercellular adhesion to endothelial cells and may inhibit recruitment of leukocytes into sites of inflammation and graft rejection. Mycophenolate mofetil did not inhibit early events in the activation of human peripheral blood mononuclear cells, such as the production of interleukin-1 (IL-1) and interleukin-2 (IL-2), but did block the coupling of these events to DNA synthesis and proliferation. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D000995 - Antitubercular Agents C471 - Enzyme Inhibitor > C2087 - Inosine Monophosphate Dehydrogenase Inhibitor C308 - Immunotherapeutic Agent > C574 - Immunosuppressant D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors
Dextrorphan O-glucuronide
Dextrorphan O-glucuronide is a natural human metabolite of Dextrorphan generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. Dextrorphan O-glucuronide is a natural human metabolite of Dextrorphan generated in the liver by UDP glucuonyltransferase.
Ricolinostat
D004791 - Enzyme Inhibitors > D056572 - Histone Deacetylase Inhibitors C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent D000970 - Antineoplastic Agents
Belotecan
(Z)-1-[4-(4-Diethylaminobutoxy)phenyl]-1,2-diphenyl-2-chloro-ethylene
6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)-4-methyl-4-hexenoic acid 2-(4-morpholinyl)ethyl ester
Penethamate
8-((4-Amino-1-methylbutyl)amino)-6-methoxy-4-methyl-5-(3-trifluoromethylphenoxy)quinoline
Ilicicolin H
An aromatic ketone in which the ketone carbonyl group is attached to a (1R,2R,4aS,7S,8aR)-4,7-dimethyl-1-[(1E)-prop-1-en-1-yl]-1,2,4a,5,6,7,8,8a-octahydronaphthalen-2-yl group and a 4-hydroxy-5-(4-hydroxyphenyl)-2-oxo-1,2-dihydropyridin-3-yl group. Isolated from the from the "imperfect" fungus Cylindrocladium iliciola strain MFC-870.
nortropane-3alpha,7beta-diol 3-(2-methylpropanoate) 7-cis-(3,4,5-trimethoxycinnamate)
Ala Cys Ile Gln
Ala Cys Leu Gln
Ala Cys Gln Ile
Ala Cys Gln Leu
Ala Asp Lys Thr
Ala Asp Thr Lys
Ala Glu Lys Ser
Ala Glu Ser Lys
Ala Gly Met Arg
Ala Gly Arg Met
Ala Ile Cys Gln
Ala Ile Gln Cys
Ala Lys Asp Thr
Ala Lys Glu Ser
Ala Lys Ser Glu
Ala Lys Thr Asp
Ala Leu Cys Gln
Ala Leu Gln Cys
Ala Met Gly Arg
Ala Met Asn Val
Ala Met Arg Gly
Ala Met Val Asn
Ala Asn Met Val
Ala Asn Val Met
Ala Gln Cys Ile
Ala Gln Cys Leu
Ala Gln Ile Cys
Ala Gln Leu Cys
Ala Arg Gly Met
Ala Arg Met Gly
Ala Ser Glu Lys
Ala Ser Lys Glu
Ala Thr Asp Lys
Ala Thr Lys Asp
Ala Val Met Asn
Ala Val Asn Met
Cys Ala Ile Gln
Cys Ala Leu Gln
Cys Ala Gln Ile
Cys Ala Gln Leu
Cys Gly Arg Val
Cys Gly Val Arg
Cys Ile Ala Gln
Cys Ile Gln Ala
Cys Lys Pro Ser
Cys Lys Ser Pro
Cys Leu Ala Gln
Cys Leu Gln Ala
Cys Asn Val Val
Cys Pro Lys Ser
Cys Pro Ser Lys
Cys Gln Ala Ile
Cys Gln Ala Leu
Cys Gln Ile Ala
Cys Gln Leu Ala
Cys Arg Gly Val
Cys Arg Val Gly
Cys Ser Lys Pro
Cys Ser Pro Lys
Cys Val Gly Arg
Cys Val Asn Val
Cys Val Arg Gly
Cys Val Val Asn
Asp Ala Lys Thr
Asp Ala Thr Lys
Asp Lys Ala Thr
Asp Lys Thr Ala
Asp Thr Ala Lys
Asp Thr Lys Ala
Glu Ala Lys Ser
Glu Ala Ser Lys
Glu Gly Lys Thr
Glu Gly Thr Lys
Glu Lys Ala Ser
Glu Lys Gly Thr
Glu Lys Ser Ala
Glu Lys Thr Gly
Glu Ser Ala Lys
Glu Ser Lys Ala
Glu Thr Gly Lys
Glu Thr Lys Gly
Gly Ala Met Arg
Gly Ala Arg Met
Gly Cys Arg Val
Gly Cys Val Arg
Gly Glu Lys Thr
Gly Glu Thr Lys
Gly Ile Met Asn
Gly Ile Asn Met
Gly Lys Glu Thr
Gly Lys Thr Glu
Gly Leu Met Asn
Gly Leu Asn Met
Gly Met Ala Arg
Gly Met Ile Asn
Gly Met Leu Asn
Gly Met Asn Ile
Gly Met Asn Leu
Gly Met Gln Val
Gly Met Arg Ala
Gly Met Val Gln
Gly Asn Ile Met
Gly Asn Leu Met
Gly Asn Met Ile
Gly Asn Met Leu
Gly Gln Met Val
Gly Gln Val Met
Gly Arg Ala Met
Gly Arg Cys Val
Gly Arg Met Ala
Gly Arg Val Cys
Gly Thr Glu Lys
Gly Thr Lys Glu
Gly Val Cys Arg
Gly Val Met Gln
Gly Val Gln Met
Gly Val Arg Cys
Ile Ala Cys Gln
Ile Ala Gln Cys
Ile Cys Ala Gln
Ile Cys Gln Ala
Ile Gly Met Asn
Ile Gly Asn Met
Ile Met Gly Asn
Ile Met Asn Gly
Ile Asn Gly Met
Ile Asn Met Gly
Ile Asn Ser Thr
Ile Asn Thr Ser
Ile Gln Ala Cys
Ile Gln Cys Ala
Ile Gln Ser Ser
Ile Ser Asn Thr
Ile Ser Gln Ser
Ile Ser Ser Gln
Ile Ser Thr Asn
Ile Thr Asn Ser
Ile Thr Ser Asn
Lys Ala Asp Thr
Lys Ala Glu Ser
Lys Ala Ser Glu
Lys Ala Thr Asp
Lys Cys Pro Ser
Lys Cys Ser Pro
Lys Asp Ala Thr
Lys Asp Thr Ala
Lys Glu Ala Ser
Lys Glu Gly Thr
Lys Glu Ser Ala
Lys Glu Thr Gly
Lys Gly Glu Thr
Lys Gly Thr Glu
Lys Pro Cys Ser
Lys Pro Ser Cys
Lys Ser Ala Glu
Lys Ser Cys Pro
Lys Ser Glu Ala
Lys Ser Pro Cys
Lys Thr Ala Asp
Lys Thr Asp Ala
Lys Thr Glu Gly
Lys Thr Gly Glu
Leu Ala Cys Gln
Leu Ala Gln Cys
Leu Cys Ala Gln
Leu Cys Gln Ala
Leu Gly Met Asn
Leu Gly Asn Met
Leu Met Gly Asn
Leu Met Asn Gly
Leu Asn Gly Met
Leu Asn Met Gly
Leu Asn Ser Thr
Leu Asn Thr Ser
Leu Gln Ala Cys
Leu Gln Cys Ala
Leu Gln Ser Ser
Leu Ser Asn Thr
Leu Ser Gln Ser
Leu Ser Ser Gln
Leu Ser Thr Asn
Leu Thr Asn Ser
Leu Thr Ser Asn
Met Ala Gly Arg
Met Ala Asn Val
Met Ala Arg Gly
Met Ala Val Asn
Met Gly Ala Arg
Met Gly Ile Asn
Met Gly Leu Asn
Met Gly Asn Ile
Met Gly Asn Leu
Met Gly Gln Val
Met Gly Arg Ala
Met Gly Val Gln
Met Ile Gly Asn
Met Ile Asn Gly
Met Leu Gly Asn
Met Leu Asn Gly
Met Asn Ala Val
Met Asn Gly Ile
Met Asn Gly Leu
Met Asn Ile Gly
Met Asn Leu Gly
Met Asn Val Ala
Met Gln Gly Val
Met Gln Val Gly
Met Arg Ala Gly
Met Arg Gly Ala
Met Val Ala Asn
Met Val Gly Gln
Met Val Asn Ala
Met Val Gln Gly
Asn Ala Met Val
Asn Ala Val Met
Asn Cys Val Val
Asn Gly Ile Met
Asn Gly Leu Met
Asn Gly Met Ile
Asn Gly Met Leu
Asn Ile Gly Met
Asn Ile Met Gly
Asn Ile Ser Thr
Asn Ile Thr Ser
Asn Leu Gly Met
Asn Leu Met Gly
Asn Leu Ser Thr
Asn Leu Thr Ser
Asn Met Ala Val
Asn Met Gly Ile
Asn Met Gly Leu
Asn Met Ile Gly
Asn Met Leu Gly
Asn Met Val Ala
Asn Ser Ile Thr
Asn Ser Leu Thr
Asn Ser Thr Ile
Asn Ser Thr Leu
Asn Thr Ile Ser
Asn Thr Leu Ser
Asn Thr Ser Ile
Asn Thr Ser Leu
Asn Thr Thr Val
Asn Thr Val Thr
Asn Val Ala Met
Asn Val Cys Val
Asn Val Met Ala
Asn Val Thr Thr
Asn Val Val Cys
Pro Cys Lys Ser
Pro Cys Ser Lys
Pro Lys Cys Ser
Pro Lys Ser Cys
Pro Ser Cys Lys
Pro Ser Lys Cys
Gln Ala Cys Ile
Gln Ala Cys Leu
Gln Ala Ile Cys
Gln Ala Leu Cys
Gln Cys Ala Ile
Gln Cys Ala Leu
Gln Cys Ile Ala
Gln Cys Leu Ala
Gln Gly Met Val
Gln Gly Val Met
Gln Ile Ala Cys
Gln Ile Cys Ala
Gln Ile Ser Ser
Gln Leu Ala Cys
Gln Leu Cys Ala
Gln Leu Ser Ser
Gln Met Gly Val
Gln Met Val Gly
Gln Ser Ile Ser
Gln Ser Leu Ser
Gln Ser Ser Ile
Gln Ser Ser Leu
Gln Ser Thr Val
Gln Ser Val Thr
Gln Thr Ser Val
Gln Thr Val Ser
Gln Val Gly Met
Gln Val Met Gly
Gln Val Ser Thr
Gln Val Thr Ser
Arg Ala Gly Met
Arg Ala Met Gly
Arg Cys Gly Val
Arg Cys Val Gly
Arg Gly Ala Met
Arg Gly Cys Val
Arg Gly Met Ala
Arg Gly Val Cys
Arg Met Ala Gly
Arg Met Gly Ala
Arg Val Cys Gly
Arg Val Gly Cys
Ser Ala Glu Lys
Ser Ala Lys Glu
Ser Cys Lys Pro
Ser Cys Pro Lys
Ser Glu Ala Lys
Ser Glu Lys Ala
Ser Ile Asn Thr
Ser Ile Gln Ser
Ser Ile Ser Gln
Ser Ile Thr Asn
Ser Lys Ala Glu
Ser Lys Cys Pro
Ser Lys Glu Ala
Ser Lys Pro Cys
Ser Leu Asn Thr
Ser Leu Gln Ser
Ser Leu Ser Gln
Ser Leu Thr Asn
Ser Asn Ile Thr
Ser Asn Leu Thr
Ser Asn Thr Ile
Ser Asn Thr Leu
Ser Pro Cys Lys
Ser Pro Lys Cys
Ser Gln Ile Ser
Ser Gln Leu Ser
Ser Gln Ser Ile
Ser Gln Ser Leu
Ser Gln Thr Val
Ser Gln Val Thr
Ser Ser Ile Gln
Ser Ser Leu Gln
Ser Ser Gln Ile
Ser Ser Gln Leu
Ser Thr Ile Asn
Ser Thr Leu Asn
Ser Thr Asn Ile
Ser Thr Asn Leu
Ser Thr Gln Val
Ser Thr Val Gln
Ser Val Gln Thr
Ser Val Thr Gln
Thr Ala Asp Lys
Thr Ala Lys Asp
Thr Asp Ala Lys
Thr Asp Lys Ala
Thr Glu Gly Lys
Thr Glu Lys Gly
Thr Gly Glu Lys
Thr Gly Lys Glu
Thr Ile Asn Ser
Thr Ile Ser Asn
Thr Lys Ala Asp
Thr Lys Asp Ala
Thr Lys Glu Gly
Thr Lys Gly Glu
Thr Leu Asn Ser
Thr Leu Ser Asn
Thr Asn Ile Ser
Thr Asn Leu Ser
Thr Asn Ser Ile
Thr Asn Ser Leu
Thr Asn Thr Val
Thr Asn Val Thr
Thr Gln Ser Val
Thr Gln Val Ser
Thr Ser Ile Asn
Thr Ser Leu Asn
Thr Ser Asn Ile
Thr Ser Asn Leu
Thr Ser Gln Val
Thr Ser Val Gln
Thr Thr Asn Val
Thr Thr Val Asn
Thr Val Asn Thr
Thr Val Gln Ser
Thr Val Ser Gln
Thr Val Thr Asn
Val Ala Met Asn
Val Ala Asn Met
Val Cys Gly Arg
Val Cys Asn Val
Val Cys Arg Gly
Val Cys Val Asn
Val Gly Cys Arg
Val Gly Met Gln
Val Gly Gln Met
Val Gly Arg Cys
Val Met Ala Asn
Val Met Gly Gln
Val Met Asn Ala
Val Met Gln Gly
Val Asn Ala Met
Val Asn Cys Val
Val Asn Met Ala
Val Asn Thr Thr
Val Asn Val Cys
Val Gln Gly Met
Val Gln Met Gly
Val Gln Ser Thr
Val Gln Thr Ser
Val Arg Cys Gly
Val Arg Gly Cys
Val Ser Gln Thr
Val Ser Thr Gln
Val Thr Asn Thr
Val Thr Gln Ser
Val Thr Ser Gln
Val Thr Thr Asn
Val Val Cys Asn
Val Val Asn Cys
Dextrorphan O-glucuronide
Belotecan
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01C - Plant alkaloids and other natural products > L01CE - Topoisomerase 1 (top1) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059004 - Topoisomerase I Inhibitors C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor D004791 - Enzyme Inhibitors
Ethanone, 1-[3-ethyl-4-(hydroxymethyl)phenyl]-,O-[[4-cyclohexyl-3-(trifluoromethyl)phenyl]methyl]oxime, (1E)-
Drotaverine hydrochloride
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent D002491 - Central Nervous System Agents > D000700 - Analgesics D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
(2R)-N-Hydroxy-2-[(3S)-3-methyl-3-{4-[(2-methylquinolin-4-YL)methoxy]phenyl}-2-oxopyrrolidin-1-YL]propanamide
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
(7R)-7-[[3,6-Dideoxy-4-O-(1H-indol-3-ylcarbonyl)-alpha-L-arabino-hexopyranosyl]oxy]octanoic acid
6-[[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]methyl]-N2-(3-methylphenyl)-1,3,5-triazine-2,4-diamine
{1-[2-(1-Formyl-propyl)-3-methanesulfonylamino-pyrrolidine-1-carbonyl]-2-methyl-propyl}-carbamic acid tert-butyl ester
Ricolinostat
D004791 - Enzyme Inhibitors > D056572 - Histone Deacetylase Inhibitors C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent D000970 - Antineoplastic Agents
Levallorphan Tartrate
C78272 - Agent Affecting Nervous System > C681 - Opiate Antagonist
(Z)-1-[4-(4-Diethylaminobutoxy)phenyl]-1,2-diphenyl-2-chloro-ethylene
4-[(4-benzylpiperazin-1-yl)acetyl]-9-hydroxy-1,2,3,4-tetrahydro-5H-chromeno[3,4-b]pyridin-5-one
1-Hydroxyprotostemonine, (rel)-
A natural product found in Stemona curtisii.
3,4-Dimethoxybenzaldehyde [4-anilino-6-(1-piperidinyl)-1,3,5-triazin-2-yl]hydrazone
N-(6-amino-1-benzyl-2,4-dioxopyrimidin-5-yl)-N-ethyl-2-(2-methyl-2,3-dihydroindol-1-yl)acetamide
2-(2-ethyl-6-methyl-3-oxo-1,4-benzoxazin-4-yl)-N-[(5-methyl-2-furanyl)methyl]-N-(3-pyridinylmethyl)acetamide
2-[(3R,6aR,8R,10aR)-3-hydroxy-1-(1,3-oxazol-4-ylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3-fluorophenyl)methyl]acetamide
N-[(E)-(2-hydroxynaphthalen-1-yl)methylideneamino]-N-(2-hydroxyphenyl)octanediamide
2-[(3R,6aS,8R,10aS)-3-hydroxy-1-(4-oxazolylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3-fluorophenyl)methyl]acetamide
(2S,3S,3aR,9bR)-1-acetyl-7-(1-cyclopentenyl)-3-(hydroxymethyl)-6-oxo-N-phenyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(2R,3R,3aS,9bS)-1-acetyl-7-(1-cyclopentenyl)-3-(hydroxymethyl)-6-oxo-N-phenyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
N-benzoyl-L-valylglycine 4-methoxy-2-naphthylamide
(3R,8aS)-2,2,9,9-tetramethyl-10-oxidospiro[6,7,8,8a-tetrahydro-2H-pyrrolo[1,2-a]pyrazine-3,7-8H-pyrano[2,3-b]carbazol-10-ium]-1,4-dione
Mycophenolate Mofetil
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D000995 - Antitubercular Agents C471 - Enzyme Inhibitor > C2087 - Inosine Monophosphate Dehydrogenase Inhibitor C308 - Immunotherapeutic Agent > C574 - Immunosuppressant D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors